APDA Diversity in Parkinson’s Disease Research Roundtable with Dr. Karen Hegland.
Karen Hegland, PhD is an Associate Professor in the Department of Speech, Language and Hearing Sciences at the University of Florida, where she also serves as Associate Department Chair and Program Director of the Master's program for Speech-Language Pathology. She is the Principal Investigator of the Laboratory for the study of Upper Airway Dysfunction (UAD lab), whose mission it is to improve clinical outcomes and quality of life in patients with speech, swallow and/or cough disorders through research, clinical care, and education. Dr. Hegland's research interests include disorders of the upper airway and respiratory systems resulting from neurodegenerative diseases, with a focus on Parkinson disease (PD) and atypical forms of Parkinsonism. Dr. Hegland received her PhD in 2006 from the University of Florida and then went on to complete a Career Development Award through Veterans Affairs (VA) at the Malcom Randall VA Medical Center in Gainesville, Florida. Following that, she completed NIH-funded postdoctoral training under the mentorship of Dr. Paul Davenport, where she focused on respiratory physiology and respiratory somatosensation. She joined the faculty at the University of Florida in 2012 and was granted tenure and promotion in 2018. She has been funded by the NIH since 2014, and her highly collaborative research has led to advances in the understanding and management of airway protection disorders in PD. Dr. Hegland's current studies are focused on understanding the impact of deep brain stimulation (DBS) on upper airway functions in people with PD, as well as disparities in the utilization of DBS among different patient groups.
Негізгі бет Low Utilization of Deep Brain Stimulation (DBS) Therapy among Minoritized Individuals with PD
Пікірлер